Video Link: https://www.youtube.com/watch?v=O4JcpkL2O7M

Imaging Nanoparticles and Validation of Specificity in In-Vivo Animal Models
New nanoparticles and nanotechnology designed for medical applications require rigorous evaluation both in vitro and in vivo. The purpose of many of these nanoparticles is to improve the treatment of disease through improved specificity, delivery of novel therapeutics, improved delivery of existing therapeutics, or delivery of novel combinations of therapeutics. In other cases, the goal of the nanoparticle may be improved detection or stratification of a disease. In all cases, in vivo imaging provides nanoparticle researchers a route to quickly validate the delivery, specificity, and efficacy of their novel therapeutics and imaging biomarkers in preclinical animal models. This presentation will review how multimodal molecular imaging can rapidly provide researchers a clear understanding of the delivery and efficacy of novel nanoparticles in preclinical animal models.From:BrukerBioSpin PCIViews:0 0ratingsTime:34:31More inScience Technology

Read the original:

Imaging Nanoparticles and Validation of Specificity in In-Vivo Animal Models - Video